Two Sigma Advisers LP Grows Holdings in Medifast, Inc. (NYSE:MED)

Two Sigma Advisers LP raised its position in Medifast, Inc. (NYSE:MED - Free Report) by 86.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 216,000 shares of the specialty retailer's stock after acquiring an additional 99,900 shares during the quarter. Two Sigma Advisers LP owned approximately 1.97% of Medifast worth $3,806,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in MED. Nisa Investment Advisors LLC lifted its stake in Medifast by 2,308.8% in the fourth quarter. Nisa Investment Advisors LLC now owns 11,442 shares of the specialty retailer's stock worth $202,000 after acquiring an additional 10,967 shares during the last quarter. Exchange Traded Concepts LLC lifted its position in shares of Medifast by 4.1% during the 4th quarter. Exchange Traded Concepts LLC now owns 17,106 shares of the specialty retailer's stock worth $301,000 after buying an additional 674 shares during the last quarter. Prescott Group Capital Management L.L.C. purchased a new stake in shares of Medifast during the 4th quarter worth approximately $1,938,000. Amundi purchased a new stake in shares of Medifast during the 4th quarter worth approximately $374,000. Finally, American Century Companies Inc. lifted its position in shares of Medifast by 3.4% during the 4th quarter. American Century Companies Inc. now owns 244,185 shares of the specialty retailer's stock worth $4,303,000 after buying an additional 8,058 shares during the last quarter. Hedge funds and other institutional investors own 95.51% of the company's stock.

Medifast Stock Performance

MED traded down $0.36 during trading on Wednesday, hitting $13.50. The stock had a trading volume of 109,240 shares, compared to its average volume of 291,471. The firm has a market capitalization of $148.38 million, a P/E ratio of 75.00 and a beta of 0.96. The company's 50-day moving average price is $13.07 and its 200 day moving average price is $15.38. Medifast, Inc. has a twelve month low of $11.57 and a twelve month high of $26.53.

Medifast (NYSE:MED - Get Free Report) last announced its quarterly earnings data on Monday, April 28th. The specialty retailer reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.04). The firm had revenue of $115.73 million during the quarter, compared to analyst estimates of $114.85 million. Medifast had a net margin of 0.35% and a return on equity of 10.64%. As a group, equities analysts expect that Medifast, Inc. will post 0.51 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on MED shares. Wall Street Zen upgraded shares of Medifast from a "hold" rating to a "buy" rating in a research report on Thursday, May 1st. DA Davidson reduced their price objective on shares of Medifast from $17.00 to $16.50 and set a "neutral" rating for the company in a research report on Wednesday, February 19th.

Medifast Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.